You searched for metabolic diseases - Page 33 of 64

News and Trends 2 Aug 2022

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

A new drug discovery collaboration has taken place between Japanese Sosei Group Corporation and UK-based Abbvie with the hope of targeting neurological disease. This is the second partnership between the…

August 2, 2022 - 2 minutesmins - By Liza Laws

News and Trends 30 Nov 2017

Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology

…diseases, but they also have wider effects, modulating the immune system, metabolism and neurological function too. By better understanding its functionality, the microbiome could be used to treat diseases like…

November 30, 2017 - 3 minutesmins - By Alex Dale

Best in Biotech 11 Apr 2024

Seven companies leading the mRNA revolution in biotechnology

…division and metabolism. As a result, therapies that harness mRNAs can help combat a range of diseases. mRNA vaccines became hugely popular in the race to develop a COVID-19 vaccine….

April 11, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 21 Mar 2019

UK Government’s Bid on Healthcare Genomics Already Benefiting Biotechs

…The company uses machine learning to mine genomic data and predict the outcome of therapy for various diseases, with a focus on advancing personalized medicine. Using its technology, Genomics announced…

March 21, 2019 - 5 minutesmins - By Helen Albert

News and Trends 12 Jul 2021

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

…in seed funding to fuel the development of treatments for rare inherited diseases. Sofinnova’s move follows a €20M injection through the same fund last year in three other early-stage Italian…

July 12, 2021 - 5 minutesmins - By Anita Chakraverty

Best in Biotech 23 May 2025

Finland: Pushing biotech forward in the land of a thousand lakes

…round in January 2025 Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by…

May 23, 2025 - 10 minutesmins - By Jules Adam

News and Trends 7 May 2025

Top biotech deals of April 2025

…of the latter’s bispecific antibodies, HXN-1002 and HXN-1003, to treat autoimmune and inflammatory bowel diseases. Earendil will receive $125 million upfront and is eligible to receive up to $1.72 billion…

May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 27 Jan 2023

Dupixent gets EU nod for children with severe atopic dermatitis

…co-morbid diseases. These diseases include approved indications for Dupixent, such as atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP) and prurigo nodularis, as well as investigational diseases such as…

January 27, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

Research looks to make drug appear like brain tumor ‘food’

…The results have been published in Pharmaceutics (Adekeye, Needham et al. 2023), in a new paper entitled, “Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable…

March 8, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 4 May 2016

How the UK is Engineering Bacteria to produce Propane for Greener Fuels

…was to ‘persuade’ a suitable microbe (the ever so versatile E. coli) to use it – which is where metabolic engineering comes in. Because the metabolic network of a microbe…

May 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

Bioplastics feature update biopolymer header

In Depth 14 Jan 2019

Life in Bioplastic, it’s More Fantastic

…There are other highly-versatile polymers but there are no known natural metabolic pathways. Metabolic and protein engineering can help. Carbios announced in 2016 that it had managed to create a…

January 14, 2019 - 10 minutesmins - By Denise Neves Gameiro

In Depth 6 Jun 2022

Releasing the microbiome’s potential to restore European soils

…groups that are already in the soil. To do this, we have found that assessing metabolic diversity and metabolic rate is far more important than getting the list of microbial…

June 6, 2022 - 9 minutesmins - By Carlos de Rojas

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology

Seven companies leading the mRNA revolution in biotechnology

UK Government’s Bid on Healthcare Genomics Already Benefiting Biotechs

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

Finland: Pushing biotech forward in the land of a thousand lakes

Top biotech deals of April 2025

Dupixent gets EU nod for children with severe atopic dermatitis

Research looks to make drug appear like brain tumor ‘food’

How the UK is Engineering Bacteria to produce Propane for Greener Fuels

Life in Bioplastic, it’s More Fantastic

Releasing the microbiome’s potential to restore European soils

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!